Locations:
Inconsistent regulation and limited toxicology tests present diagnostic and treatment challenges
Milestone case report expands understanding of infectious risks for those on immunomodulatory therapies
Advanced technologies are changing expectations about what’s possible
A rare opportunity to design for speed, care coordination, recovery and continuous monitoring
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Multidisciplinary, proactive approach also improved discharge outcomes
Phase 1 Breakfree-2 trial reports good safety and efficacy at week 26
Inflammatory protein eotaxin-1 may be a marker of future cognitive decline
Therapists and physicians collaborate to get medically stable patients moving
Designed for digitization, distance health, discovery and more
Combining customized care, research capabilities and flexibility for the future
Advertisement
Advertisement
Search